• Research and Development

  Bias Likely Explains Link Between Antacids and Reduced Mortality in IPF Research

  Posted by Pulmonary Fibrosis News Moderator on July 17, 2018 at 2:37 pm

  A new review study suggests that a specific type of bias likely explains the reported benefits of antacid therapy in the survival of IPF patients.

  Click here to read more about the impact of bias in IPF research.

  What are your thoughts on this news? Do you think it’s possible to eliminate bias completely in research? How?

  Pulmonary Fibrosis News Moderator replied 5 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply